HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Atsuo Taniguchi Selected Research

Atsuo Taniguchi Research Topics

Disease

35	Rheumatoid Arthritis 12/2015 - 04/2002
6	Gout 09/2015 - 03/2008
4	Pain (Aches) 01/2016 - 12/2005
4	Hyperuricemia 09/2015 - 01/2003
2	Urolithiasis 04/2008 - 10/2004
2	Drug Toxicity (Drug Safety) 01/2008 - 12/2002
1	Herpes Zoster 07/2015
1	Radius Fractures (Radius Fracture) 04/2014
1	Vitamin D Deficiency 07/2013
1	Ankylosis 10/2012
1	Osteolysis 10/2012
1	Psoriatic Arthritis 10/2012
1	Joint Diseases (Joint Disease) 10/2012
1	Acute Kidney Injury (Acute Renal Failure) 04/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2012
1	Lung Diseases (Lung Disease) 12/2011
1	Kidney Calculi (Kidney Stone) 12/2011
1	Osteoporotic Fractures 08/2011
1	Osteoporosis 08/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2010
1	Hypertension (High Blood Pressure) 11/2010
1	Pneumonia (Pneumonitis) 06/2010
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 03/2008
1	Fasciitis (Fascitis) 01/2008
1	Panniculitis 01/2008
1	Cystic Kidney Diseases (Cystic Kidney Disease) 05/2004
1	Gouty Arthritis 09/2002

Drug/Important Bio-Agent (IBA)

9	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 04/2002
8	Uric Acid (Urate)IBA 09/2015 - 09/2002
5	Antirheumatic Agents (DMARD)IBA 05/2015 - 12/2002
4	ametantrone (HAQ)IBA 01/2016 - 12/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2007
3	Rheumatoid FactorIBA 12/2015 - 10/2012
3	Prednisolone (Predate)FDA LinkGeneric 07/2015 - 01/2008
3	HLA-DRB1 antigen (HLA DRB1)IBA 05/2015 - 06/2012
3	cyclic citrullinated peptideIBA 01/2014 - 05/2011
3	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2009 - 04/2002
2	tocilizumab FDA Link 07/2015 - 11/2013
2	AntibodiesIBA 05/2015 - 01/2015
2	SodiumIBA 06/2010 - 03/2008
2	2,8-dihydroxyadenineIBA 04/2008 - 10/2004
2	Adenine PhosphoribosyltransferaseIBA 04/2008 - 10/2004
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 12/2002 - 12/2002
1	febuxostat FDA Link 09/2015
1	golimumab FDA Link 07/2015
1	acetyl 4-aminosalicylic acidIBA 05/2015
1	Interleukin-15 (Interleukin 15)IBA 04/2014
1	arginine deiminaseIBA 01/2014
1	25-hydroxyvitamin DIBA 01/2014
1	OsteoprotegerinIBA 01/2014
1	hydroxide ionIBA 07/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2013
1	ruberythric acid (AlP)IBA 07/2013
1	CholesterolIBA 07/2013
1	TNFR-Fc fusion protein (etanercept)FDA Link 03/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013
1	diazenedicarboxylic acid bis(N'-methylpiperazide)IBA 10/2012
1	Renal hypouricemiaIBA 04/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2011
1	Adenine phosphoribosyltransferase deficiencyIBA 12/2011
1	DiphosphonatesIBA 08/2011
1	Immunoglobulin G (IgG)IBA 05/2011
1	SialomucinsIBA 02/2011
1	DiureticsIBA 11/2010
1	Lactic Acid FDA LinkGeneric 03/2008
1	Butyrates (Butyrate)IBA 03/2008
1	UromodulinIBA 03/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2008
1	Cimetidine (Biomet)FDA LinkGeneric 01/2008
1	Amyloid (Amyloid Fibrils)IBA 12/2007
1	Hepatocyte Nuclear Factor 1-betaIBA 05/2004
1	EnzymesIBA 12/2002

Therapy/Procedure

2	Arthroplasty 10/2011 - 10/2010
1	Self-Help Devices (Assistive Technology) 07/2013
1	Complementary Therapies (Alternative Medicine) 07/2013
1	Biological Therapy 03/2013
1	Intra-Articular Injections 01/2009
1	Injections 01/2009
1	Individualized Medicine 02/2007
1	Exercise Therapy (Therapy, Exercise) 01/2003